Rare APOE Variants Reduce Alzheimer’s Risk by More Than 60%

Two rare missense mutations in APOE ε3 and ε4 isoforms reduce the risk of Alzheimer's disease by 50% or more and may serve as novel drug targets.
Medscape Medical News
Two rare missense mutations in APOE ε3 and ε4 isoforms reduce the risk of Alzheimer’s disease by 50% or more and may serve as novel drug targets.
Medscape Medical News